Canine atopic dermatitis treatment drugs market
Canine Atopic Dermatitis Treatment Drugs Market, By Drug Class (Janus Kinase Inhibitors, Antihistamines, Monoclonal Antibodies, Antibiotics, Allergic Immunotherapy/Desensitization Therapy, and Others), By Route of Administration (Injectable, Oral, and Topical), By Dosage Form (Tablets, Creams, Spray, and Others), By Distribution Channel (Online and Offline), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
- Apr 2024
- CMI4886
- 165 Pages
- Excel & Pdf
- Pharmaceutical
Summary
N/A
Table of Content
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Class
- Market Snapshot, By Route of Administration
- Market Snapshot, By Dosage Form
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Recent Developments
- Brand and Pricing Analysis
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Product Launches/Approvals
- Funding and Investments
- PEST Analysis
- Porter’s Analysis
- Market Dynamics
- Global Canine Atopic Dermatitis Treatment Drugs Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 impact on the market
- Global Canine Atopic Dermatitis Treatment Drugs Market, By Drug Class, 2019 – 2031, (USD Mn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 – 2031
- Segment Trends
- Janus Kinase Inhibitors
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
- Antihistamines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
- Monoclonal Antibodies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
- Antibiotics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
- Allergic Immunotherapy/Desensitization Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
- Overview
- Global Canine Atopic Dermatitis Treatment Drugs Market, By Route of Administration, 2019 – 2031, (USD Mn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 – 2031
- Segment Trends
- Injectable
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
- Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
- Topical
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
- Overview
- Global Canine Atopic Dermatitis Treatment Drugs Market, By Dosage Form, 2019 – 2031, (USD Mn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 – 2031
- Segment Trends
- Tablets
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
- Creams
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
- Spray
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
- Overview
- Global Canine Atopic Dermatitis Treatment Drugs Market, By Distribution Channel, 2019 – 2031, (USD Mn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 – 2031
- Segment Trends
- Online
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
- Offline
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
- Overview
- Global Canine Atopic Dermatitis Treatment Drugs Market, By Region, 2019 – 2031, (USD Mn)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Regions, 2019–2031
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (USD Mn)
- North Africa
- Central Africa
- South Africa
- Introduction
- Competitive Landscape
- Company Profiles
- Bioiberica S.A.U
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Dechra Pharmaceuticals PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Elanco
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- NIPPON ZENYAKU KOGYO CO., LTD
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Vimian
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- TORAY INDUSTRIES, INC.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Zoetis
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Virbac
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Ceva
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bimeda, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Vivaldis
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- VetriMax Veterinary Products
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Vetoquinol
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Royal Canin North America
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bioiberica S.A.U
- Company Profiles
- Analyst View
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
- References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
*Browse 34 market data tables and 30 figures on “Canine Atopic Dermatitis Treatment Drugs Market” -Global forecast to 2031
Segmentation
Detailed Segmentation-
- Drug Class:
- Janus Kinase Inhibitors
- Antihistamines
- Monoclonal Antibodies
- Antibiotics
- Allergic Immunotherapy/Desensitization Therapy
- Others
- Route of Administration:
- Injectable
- Oral
- Topical
- Dosage Form:
- Tablets
- Creams
- Spray
- Others
- Distribution Channel:
- Online
- Offline
- Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Frequently Asked Questions -
What will be the CAGR of the canine atopic dermatitis treatment drugs market?
The CAGR of the canine atopic dermatitis treatment drugs market is projected to be 10.1% from 2024 to 2031.
What are the major factors driving the canine atopic dermatitis treatment drugs market growth?
Rising research & development activities and increasing number of approvals from regulatory agencies and increasing prevalence of canine atopic dermatitis are the major factors driving the growth of the canine atopic dermatitis treatment drugs market.
What are the key factors hampering the growth of the canine atopic dermatitis treatment drugs market?
High cost associated with canine atopic dermatitis treatment drugs and side effects and safety concerns are the major factors hampering the growth of the canine atopic dermatitis treatment drugs market.
Which is the leading drug class in the canine atopic dermatitis treatment drugs market?
In terms of drug class, janus kinase inhibitors are estimated to dominate the market revenue share in 2024.
Which are the major players operating in the canine atopic dermatitis treatment drugs market?
Bioiberica S.A.U, Dechra Pharmaceuticals PLC, Elanco, NIPPON ZENYAKU KOGYO CO., LTD, Vimian, TORAY INDUSTRIES, INC., Zoetis, Virbac, Ceva, Bimeda, Inc., Vivaldis, VetriMax Veterinary Products, Vetoquinol, and Royal Canin North America are the major players.
Which region will lead the canine atopic dermatitis treatment drugs market?
North America is expected to lead the canine atopic dermatitis treatment drugs market.